ITGB3 and osteoarthritis: Besides, an injectable nanogel was developed to provide a sustained release of siRNA-ITGβ3 (RGD-Nanogel/siRNA-ITGβ3), which blocked SPP1-ITGβ3 interaction in infrapatellar fat pad and attenuated osteoarthritis 49.